openPR Logo
Press release

U.S. Revenue Cycle Management Market Expected to Grow at 10.1% CAGR, Reaching USD 276 Billion by 2030

10-14-2025 11:22 AM CET | IT, New Media & Software

Press release from: DataM Intelligence 4Market Research LLP

U.S. Revenue Cycle Management Market

U.S. Revenue Cycle Management Market

The U.S. revenue cycle management (RCM) market is witnessing rapid growth fueled by the transformation of healthcare systems through digitalization and the increasing complexity of medical billing and reimbursement. DataM Intelligence reports the market size at USD 172.24 billion in 2024, with an anticipated CAGR of 10.1% from 2025 to 2030. The integration of AI, electronic health records (EHR), and data analytics systems is streamlining workflow, enhancing revenue capture, and reducing administrative burdens for healthcare providers.

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/revenue-cycle-management-market?utm_source=OpenPR&utm_campaign=Onkar

The market's expansion is further driven by the increasing outsourcing of RCM services due to labor shortages, cost pressures, and regulatory complexity. The demand for integrated, web-based, and cloud solutions that enhance connectivity, interoperability, and automation is growing in response to evolving healthcare delivery models such as telemedicine and value-based care.

Key Highlights from the Report

➤ Market valued at USD 172.24 billion in 2024, expected to experience rapid growth at 10.1% CAGR through 2030.
➤ Outsourcing of RCM services is rising across hospitals, physician offices, and specialty clinics due to cost efficiency and regulatory demands.
➤ AI-powered platforms and integrated RCM solutions increasingly adopted to enhance billing accuracy and streamline workflows.
➤ Claims management remains the largest functional segment, while care management is the fastest growing due to virtual health needs.
➤ In-house RCM commands a significant market share, but outsourced services are expanding fastest.
➤ Leading companies actively pursue mergers, partnerships, and technological innovation to expand capabilities.

Market Segmentation
The U.S. RCM market is segmented by components, products, delivery modes, specialties, sourcing, and end use. Services dominate the components segment, as healthcare providers increasingly outsource billing, coding, and compliance activities to enhance efficiency. Integrated RCM solutions are preferred for their comprehensive workflow automation and data interoperability advantages. Web-based delivery models lead due to rapid deployment and affordability, while cloud-based solutions grow fast benefiting from secure, scalable infrastructure. Specialty areas like cardiology and oncology show high demand for RCM due to procedural complexity and reimbursement challenges. The market also differentiates between in-house and outsourced sourcing options, with outsourcing gaining momentum from small to large providers. Hospitals represent the largest end users, actively seeking efficiency gains and better revenue capture mechanisms.

Regional Insights
As a mature healthcare hub, the U.S. market is concentrated among key regional healthcare institutions facing increasing regulatory and economic pressures. Market players focus on expanding their geographic footprint through acquisitions and partnerships to serve diverse healthcare providers. The uneven availability of skilled medical billers and coders across regions reinforces outsourcing trends, while digital infrastructure improvements support broader adoption of technology-driven RCM.

Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/revenue-cycle-management-market?utm_source=OpenPR&utm_campaign=Onkar

Market Dynamics
Market Drivers
Rising complexity in billing and reimbursement, staff shortages, financial pressures, and stringent regulatory compliance drive healthcare providers towards innovative RCM platforms and outsourcing. Increasing adoption of AI and automation further accelerates market growth.

Market Restraints
Challenges include evolving and inconsistent regulations, high investment costs in technology deployment, and operational barriers in scaling integrated RCM systems across diverse facilities.

Market Opportunities
Emerging growth opportunities arise from telemedicine expansion, virtual care billing needs, growing prevalence of chronic diseases requiring complex management, and the rise of value-based care models enhancing demand for advanced RCM solutions.

Reasons to Buy the Report
✔ Detailed quantitative analysis of market size, growth, and trends through 2030
✔ Segmented insights across product types, delivery modes, specialties, and sourcing
✔ Profiles of leading companies and analysis of mergers, acquisitions, and partnerships
✔ Examination of technological advancements including AI and integrated systems
✔ Strategic guidance on navigating regulatory challenges and outsourcing opportunities

Purchase This Exclusive Report at Just USD 5193 Only: https://www.datamintelligence.com/buy-now-page?report=revenue-cycle-management-market?utm_source=OpenPR&utm_campaign=Onkar

Frequently Asked Questions (FAQs)
◆ How big is the U.S. revenue cycle management market in 2024?
◆ What is the projected growth rate of the market from 2025 to 2030?
◆ Which segment holds the largest market share in RCM components?
◆ Who are the key players in the U.S. revenue cycle management market?
◆ What impact does AI integration have on RCM efficiency and accuracy?

Company Insights
athenahealth, Inc.

Cerner Corporation

eClinicalWorks

Epic Systems Corporation

McKesson Corporation

NXGN Management, LLC

Oncospark, Inc.

R1 RCM, Inc.

The SSI Group, Inc.

Veradigm LLC (Allscripts Healthcare LLC)

Notable recent market developments include Access Healthcare's significant strategic investment from New Mountain Capital in January 2025 aimed at expansion. In September 2024, CorroHealth acquired Xtend healthcare's RCM business, adding over 925 employees and strengthening operational capabilities. Aidéo Technologies and MedEvolve partnered in early 2024 to boost healthcare workflow automation using AI-powered coding, enhancing revenue cycle precision and efficiency.

Conclusion
The U.S. revenue cycle management market is poised for robust growth, driven by digital transformation, outsourcing trends, and increasing adoption of AI-driven integrated platforms. Healthcare providers are focusing on cost containment, regulatory compliance, and operational efficiencies, fostering a competitive landscape rich with innovation and strategic partnerships. This momentum ensures continued expansion and modernization of RCM services to meet the evolving needs of the U.S. healthcare ecosystem through 2030.

Contact Us

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com

About Us

DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Revenue Cycle Management Market Expected to Grow at 10.1% CAGR, Reaching USD 276 Billion by 2030 here

News-ID: 4222925 • Views:

More Releases from DataM Intelligence 4Market Research LLP

Frozen Shoulder Syndrome Market Grows Amid Advances in Arthroscopic and Robotic Treatments | GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc.
Frozen Shoulder Syndrome Market Grows Amid Advances in Arthroscopic and Robotic …
The Frozen Shoulder Syndrome Market is estimated to reach at a Significant CAGR during the forecast period (2024-2031). Frozen Shoulder Syndrome, or adhesive capsulitis, is a condition marked by stiffness and pain in the shoulder joint. It occurs when the capsule surrounding the joint thickens and tightens, restricting movement. The condition often develops gradually and can last months to years. Common causes include injury, diabetes, or prolonged immobilization. Treatment includes physical
U.S. Floating Power Plant Market to Reach USD 1.4 Billion by 2035 Driven by Renewable Integration and Coastal Energy Demand
U.S. Floating Power Plant Market to Reach USD 1.4 Billion by 2035 Driven by Rene …
The U.S. floating power plant market is emerging as a pivotal solution to address growing energy demands amid limited land availability, particularly in coastal and rural areas. Floating power plants, which consist of electrical generators mounted on barges, ships, or modular rafts, offer flexible deployment and integration with renewable energy sources such as offshore wind and floating solar. DataM Intelligence estimates the market size at USD 0.3 billion in 2025,
U.S. Omega-3 Supplements Market Projected to Reach USD 3.59 Billion by 2030 Fueled by Rising Health Awareness and Innovation
U.S. Omega-3 Supplements Market Projected to Reach USD 3.59 Billion by 2030 Fuel …
The U.S. omega-3 supplements market is rapidly growing as consumers increasingly prioritize wellness, driven by escalating healthcare costs, regulatory clarity, and technological advances in supplement formulation. According to DataM Intelligence, the market was valued at approximately USD 2,027.8 million in 2023 and is expected to expand at a CAGR of 8.6% from 2024 to 2030, reaching USD 3.59 billion by the end of the forecast period. Increased prevalence of chronic
Lactoferrin Market to Reach USD 641.3 Million by 2031, Growing at 7.4% CAGR | Driven by Rising Demand in Infant Formula & Immune Health
Lactoferrin Market to Reach USD 641.3 Million by 2031, Growing at 7.4% CAGR | Dr …
The Global Lactoferrin Market reached USD 362.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 641.3 million by 2031. The market is growing at a CAGR of 7.4% during the forecast period 2024-2031. Lactoferrin is an iron-binding glycoprotein found in milk, tears, saliva, and other bodily fluids. It exhibits antimicrobial, antiviral, and anti-inflammatory properties. Lactoferrin supports immune function, promotes gut health, and enhances iron

All 5 Releases


More Releases for RCM

RCM Matter, a TechMatter Company, Introduces Next-Gen Medical Billing & RCM Soft …
GLENDALE, CA, UNITED STATES, August 27, 2025 -- RCM Matter, a subsidiary of TechMatter, announced the launch of its flagship product, a next-generation Medical Billing and Revenue Cycle Management (RCM) software solution that's built for modern-day healthcare practices. The platform empowers providers with automation, compliance, and transparency, helping them reduce administrative stress and strengthen financial performance. Built from the ground up with healthcare teams in mind, the RCM software offers
Healthcare RCM Outsourcing Market Report 2024 - RCM Outsourcing Market Trends, S …
"The Business Research Company recently released a comprehensive report on the Global Healthcare RCM Outsourcing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Murray,
Investigation announced for Investors who lost money with shares of R1 RCM Inc. …
An investigation was announced over potential securities laws violations by R1 RCM Inc. in connection with certain financial statements. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of R1 RCM Inc. (NASDAQ: RCM) concerning whether a
Investigation announced for Investors in R1 RCM Inc. (NASDAQ: RCM) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its
Investigation announced for Investors in shares of R1 RCM Inc. (NASDAQ: RCM)
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at R1 RCM Inc. Investors who purchased shares of R1 RCM Inc. (NASDAQ: RCM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain R1 RCM Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Chicago,